Trial intelligence / Profile preview

Topical Sildenafil vs Minoxidil in Male Androgenic Alopecia

NCT05369481Unknown

Start
Mar 2022
Primary completion
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of sildenafil in androgenetic alopecia (AGA) (2 arms). Primary endpoint: Improvement changes at 6 months. Status: unknown.

02

Drugs

sildenafil
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on NCT05369481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05369481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call